EMIR: Difference between revisions
imported>Doug Williamson m (Added date to ACT website link) |
imported>Doug Williamson m (Amend ACT links and categorise.) |
||
| Line 17: | Line 17: | ||
== | == Other links == | ||
[http://www.treasurers.org/otc ACT briefing note: European regulation of OTC derivatives: Implications for non-financial companies ] | [http://www.treasurers.org/otc ACT briefing note: European regulation of OTC derivatives: Implications for non-financial companies, April 2013 ] | ||
[http://www.treasurers.org/node/9406 EMIR – frequently asked questions for non financial counterparties, | [http://www.treasurers.org/node/9406 EMIR – frequently asked questions for non financial counterparties, ACT webinar September 2013] | ||
==References== | ==References== | ||
<references /> | <references /> | ||
[[Category:Capital_Markets_and_Funding]] | |||
[[Category:Managing_Risk]] | |||
Revision as of 06:03, 2 October 2013
European Market Infrastructure Regulation[1] (EMIR) came into force as binding law within the European Union on 16th August 2012, although certain of its requirements came into force after a period of delay.
The objective of EMIR is to reduce the risks posed to financial systems from the vast web of Over the counter (OTC) derivative transactions and the contingent large credit exposures that may arise as a consequence. The Regulation achieves this object by three significant requirements for:
• Central clearing and margining of standardised OTC derivatives (with certain exemptions for Non-Financial Counterparties)
• Reporting of all derivative transactions to a trade repository
• Risk mitigation measures for all non cleared derivatives including collateral exchange and confirmation and reconciliation procedures
See also
Other links
EMIR – frequently asked questions for non financial counterparties, ACT webinar September 2013
